Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia

Semin Hematol. 1993 Jul;30(3 Suppl 3):11-3.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Busulfan / administration & dosage
  • Cytarabine / administration & dosage
  • Female
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / therapeutic use*
  • Male
  • Recombinant Proteins
  • Remission Induction

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Cytarabine
  • Busulfan